REVUFORJ

REVUMENIB · Syndax Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for REVUFORJ, covering 2024-11-15 to 2025-10-24. Get the full timeline:

Most recent: FDA Approved: REVUFORJ — Supplemental Application (Syndax Pharmaceuticals, Inc.)